Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate

The invention relates to a pharmaceutical composition suitable for injection as an aqueous suspension for sustained release of a bisphosphonate drug, the composition comprising: a sosoloid containing a salt of a bisphosphonate drug; and a salt of a pentavalent phosphorus oxoacid, the sosoloid having...

Full description

Saved in:
Bibliographic Details
Main Authors XIE, KEVIN, LUO, MARY ZIPING, DING, JIE FEI, FEI, DINGYUAN, ZHANG, JACK YONGFENG
Format Patent
LanguageEnglish
Polish
Published 27.02.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to a pharmaceutical composition suitable for injection as an aqueous suspension for sustained release of a bisphosphonate drug, the composition comprising: a sosoloid containing a salt of a bisphosphonate drug; and a salt of a pentavalent phosphorus oxoacid, the sosoloid having a solubility in saline of less than 0.05% by weight as bisphosphonic acid for use as a medicament and for use in the prevention or treatment of a bone disease in a patient, in particular osteoporosis.
AbstractList The invention relates to a pharmaceutical composition suitable for injection as an aqueous suspension for sustained release of a bisphosphonate drug, the composition comprising: a sosoloid containing a salt of a bisphosphonate drug; and a salt of a pentavalent phosphorus oxoacid, the sosoloid having a solubility in saline of less than 0.05% by weight as bisphosphonic acid for use as a medicament and for use in the prevention or treatment of a bone disease in a patient, in particular osteoporosis.
Author LUO, MARY ZIPING
ZHANG, JACK YONGFENG
DING, JIE FEI
FEI, DINGYUAN
XIE, KEVIN
Author_xml – fullname: XIE, KEVIN
– fullname: LUO, MARY ZIPING
– fullname: DING, JIE FEI
– fullname: FEI, DINGYUAN
– fullname: ZHANG, JACK YONGFENG
BookMark eNqNjb0OwjAQgzPAwN87hAdggBaJHYEYOjB0r47itpHSu9BL3p9G4gEYLFvyZ3ltFiyMlekq4d5GTKPVpJEc420neJDChoGmkVqk6FrytpUxiLrohOfMGXbzmD4JkjTvA1hzK519OQ2DZDFFbM2yI6_Y_Xxj9vdbfX0cEKSBhvmEEZtndTqXl7I81nVR_MN8AaTzQ30
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate Kompozycja farmaceutyczna o długotrwałym przedłużonym uwalnianiu, zawierającą wodną zawiesinę bisfosfonianu
ExternalDocumentID PL2548441TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_PL2548441TT33
IEDL.DBID EVB
IngestDate Fri Jul 19 15:57:20 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Polish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_PL2548441TT33
Notes Application Number: PL20120186963T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150227&DB=EPODOC&CC=PL&NR=2548441T3
ParticipantIDs epo_espacenet_PL2548441TT3
PublicationCentury 2000
PublicationDate 20150227
PublicationDateYYYYMMDD 2015-02-27
PublicationDate_xml – month: 02
  year: 2015
  text: 20150227
  day: 27
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies Amphastar Pharmaceuticals Incorporation
RelatedCompanies_xml – name: Amphastar Pharmaceuticals Incorporation
Score 2.979215
Snippet The invention relates to a pharmaceutical composition suitable for injection as an aqueous suspension for sustained release of a bisphosphonate drug, the...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150227&DB=EPODOC&locale=&CC=PL&NR=2548441T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6LzgwjSt-Jc0o89FGHtxpBuK1Jlb6NpGzeQttiK_76XrNW96EOh9GhIDi6_u-R3dwB3toiYIRKu8wETGKAkkW4PHmydm6bFhKwIp5r2TWfm5IU9LYxFC9ZNLoyqE_qliiOiRcVo75Xar4vfQyxPcSvLe77GT_njOHQ8rY6O0bvp9y3NGzqjYO7NXc11ncDXZs8OxkE2In9Id2BXetGyzP7odSiTUoptRBkfwV6Ag2XVMbSK9w4cuE3jtQ7sT-v7bnytTa88AeHn2RuRGykpN0lPaUJkxxOEIVKstk-mieSJ12QsIrnomy4QJEIMwEBf_l9I3jpKc0H4uixWuXwynNEp3I5HoTvRccLLH-UsA79ZWkjpGbSzPEvPgVAjpUlMY7tHI8YTgX5crz9IWRobpmBCXED373G6_wkv4VAqWqV1W1fQrj4-02sE5orfKJV-A9oIlvY
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD7MKc43nYrOWwTpW3E26WUPRVi7MbXbilTZ2-gtbiBtsRX_vidZp3vRh0JoSEgPnHz50u-cA3Bj8ZDpPInUqMc4EpQkVK3enaVGhmEyLjLCyaJ944kxemGPM33WgOU6FkbmCf2SyRHRo2L090ru18XvJZYrtZXlbbTEV_n9MLBdpWbHeLrRNFNx-_bAn7pTR3Ec2_eUybONPMhC5A_oFmybyAhFmv3Ba18EpRSbiDLchx0fJ8uqA2gU721oOevCa23YHdf_u7FZu155CNzLszciNlJSroKe0oSIiicIQ6RYbN5ME6ETr8VYRGjRV1UgSIgYgERfjC-Ebh17c06iZVkscvFkuKIjuB4OAmek4oLnP8aZ-9760wJKj6GZ5Vl6AoTqKU1iGltdGrIo4XiO62q9lKWxbnDG-Sl0_p6n81_nFbRGwdibew-TpzPYE0aXId7mOTSrj8_0AkG6ii6leb8BECaZ4Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Long+term+sustained+release+pharmaceutical+composition+containing+aqueous+suspension+of+bisphosphonate&rft.inventor=XIE%2C+KEVIN&rft.inventor=LUO%2C+MARY+ZIPING&rft.inventor=DING%2C+JIE+FEI&rft.inventor=FEI%2C+DINGYUAN&rft.inventor=ZHANG%2C+JACK+YONGFENG&rft.date=2015-02-27&rft.externalDBID=T3&rft.externalDocID=PL2548441TT3